These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11764660)

  • 21. Head and Neck Cancers: Advantages of Advanced Radiation Therapy and Importance of Supportive Care.
    Spencer S
    J Natl Compr Canc Netw; 2018 May; 16(5S):666-669. PubMed ID: 29784752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer.
    Leslie MD; Dische S
    Radiother Oncol; 1994 Jan; 30(1):26-32. PubMed ID: 8153377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-D conformal radiotherapy in head and neck cancer. The Washington University experience.
    Emami B; Purdy JA; Simpson JR; Harms W; Gerber R; Wippold JF
    Front Radiat Ther Oncol; 1996; 29():207-20. PubMed ID: 8742901
    [No Abstract]   [Full Text] [Related]  

  • 24. [Concepts of prevention and therapy of radiation-induced side effects].
    Bornstein M; Buser D; Filippi A
    Schweiz Monatsschr Zahnmed; 2001; 111(8):962-77. PubMed ID: 11552317
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensity modulation techniques for improvement of normal tissue tolerance.
    De Neve W; Claus F; Duthoy W; De Meerleer G; De Wagter C
    Front Radiat Ther Oncol; 2002; 37():163-73. PubMed ID: 11764658
    [No Abstract]   [Full Text] [Related]  

  • 26. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 27. Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
    Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):3-6. PubMed ID: 10924965
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel radiotherapy schedules aid recovery of normal tissues after treatment.
    Fowler JF
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):7-8. PubMed ID: 20361066
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiomyelopathy after conventionally fractionated and hyperfractionated radiotherapy--experimental data and clinical consequences.
    Niewald M; Feldmann U; Feiden W; Kiessling M; Berberich W; Lehmann W; Abel U; Staut W; Büscher-Rolles E; Walter K; Nieder C; Nestle U; Deinzer M; Schnabel K
    Front Radiat Ther Oncol; 1999; 33():293-304. PubMed ID: 10549499
    [No Abstract]   [Full Text] [Related]  

  • 30. High energy (42-66 MeV reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities.
    Griffin TW; Martz KL; Laramore GE; Thomas FJ; Maor MH; Hendrickson FR; Parker RG; Richter MP; Davis LW
    Radiother Oncol; 1990 Dec; 19(4):307-16. PubMed ID: 2126633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperfractionated radiotherapy: tops or flops?
    Baumann M; Beck-Bornholdt HP
    Med Pediatr Oncol; 1999 Oct; 33(4):399-402. PubMed ID: 10491550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dose fractionation in distance radiotherapy of malignant neoplasms].
    Kozlov AP; Akimov AA
    Vopr Onkol; 1983; 29(11):105-16. PubMed ID: 6359680
    [No Abstract]   [Full Text] [Related]  

  • 33. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
    Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
    Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hazards of "low dose" irradiation to the head and neck.
    Kaplan EL
    Curr Surg; 1978; 35(6):371-2. PubMed ID: 729397
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of surgery on normal tissue toxicity in patients treated with accelerated radiotherapy.
    Wratten CR; Poulsen MG; Williamson S; Tripcony L; Keller J; Dickie G
    Acta Oncol; 2002; 41(1):56-62. PubMed ID: 11990519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy in head and neck cancer.
    Morgan DA
    J Laryngol Otol; 1997 Nov; 111(11):1005-7. PubMed ID: 9472566
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of the helium-neon laser for preventing acute radiation reactions of the skin during neutron therapy of head and neck cancer].
    Popovich VI; Musabaeva LI; Kitsmaniuk ZD; Lavrenkov KA
    Med Radiol (Mosk); 1991; 36(7):52-3. PubMed ID: 1908935
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
    Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.